Back

prof. drs. D.E.E. (Marjolein) de Coenders-Pinas

prof. drs. D.E.E. (Marjolein) de Coenders-Pinas

Full Professor

Show full profile

Research Output (154)

Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment

Bakker Daphne S., Drylewicz Julia, Nierkens Stefan, Knol Edward F., Giovannone Barbara, Delemarre Eveline M., van der Schaft Jorien, Balak Deepak M.W., de Bruin-Weller Marjolein S., Thijs Judith L. Dec 2019, In: Clinical and Experimental Allergy. 49 , p. 1641-1644 4 p.

Biomarkers detected in dried blood spots from atopic dermatitis patients strongly correlate with disease severity

Thijs Judith L., Fiechter Renée, Giovannone Barbara, de Bruin-Weller Marjolein S., Knol Edward F., Bruijnzeel-Koomen Carla A.F.M., Drylewicz Julia, Nierkens Stefan, Hijnen Dirk Jan Nov 2019, In: Allergy: European Journal of Allergy and Clinical Immunology. 74 , p. 2240-2243 4 p.

Dupilumab facial redness:Positive effect of itraconazole

de Beer Fleur S.A., Bakker Daphne S., Haeck Inge, Ariens Lieneke, van der Schaft Jorien, van Dijk Marijke R., de Bruin-Weller Marjolein S. 1 Oct 2019, In: JAAD Case Reports. 5 , p. 888-891 4 p.

Predicting treatment response to methotrexate in atopic dermatitis patients using clinical characteristics and serum biomarkers

Ariens L., Thijs J., Bakker D., Drylewicz J., Nierkens Stefan, Knol E., Delemarre E., Balak D., van der Schaft J., de Bruin-Weller M. Sep 2019, In: Journal of Investigative Dermatology. 139 , p. S287-S287

Endotyping of adult and paediatric atopic dermatitis; is it one disease?

Thijs J., Bakker D., Delemarre E., de Graaf M., Knol E., Drylewicz J., van Wijk F., Nierkens S., de Bruin-Weller M. Sep 2019, In: Journal of Investigative Dermatology. 139 , p. S285-S285

Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment

Bakker D., Drylewicz J., Nierkens S., Knol E., van der Schaft J., Delemarre E., Balak D., de Bruin-Weller M., Thijs J. Sep 2019, In: Journal of Investigative Dermatology. 139 , p. S286-S286

Ophthalmological characteristics and treatment outcomes of conjunctivitis in patients receiving dupilumab for moderate-to-severe atopic dermatitis

Lans A., Van Luijk C. M., Bakker D. S., Ariens L. F. M., Thijs J. L., Van der Schaft J., De Boer J. H., Knol E. F., De Bruin-Weller M. S., Balak D. M. W. Aug 2019, In: Allergy. 74 , p. 714-714

Dupilumab:Eerste resultaten vanuit het BioDay-register

Ariëns Lieneke F.M., van der Schaft J., Bakker D. S., Balak D. M.W., Giovannone B., Romeijn M., Kouwenhoven T., Kamsteeg M., Drylewicz J., van Wijk F., Nierkens Stefan, Thijs J. L., Schuttelaar M. L., de Bruin-Weller M. S. 1 Apr 2019, In: Nederlands Tijdschrift voor Dermatologie en Venereologie. 29 , p. 29-34 6 p.

Itraconazol bij ’red face’ tijdens dupilumabbehandeling

de Beer Fleur, Haeck I., Bakker D., Ariëns L., van der Schaft J., de Bruin-Weller M., van Dijk M. 1 Apr 2019, In: Nederlands Tijdschrift voor Dermatologie en Venereologie. 29 , p. 35-37 3 p.

EASI p-EASI:Predicting disease severity in atopic dermatitis patients treated with cyclosporin A

Thijs Judith L., Drylewicz Julia, Bruijnzeel-Koomen Carla A.F.M., Giovannone Barbara, Knol Edward F., de Bruin-Weller Marjolein S., Nierkens Stefan, Hijnen Dirk Jan 2019, In: Allergy: European Journal of Allergy and Clinical Immunology. 74 , p. 613-617 5 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not